---
schema_version: "secwatch.filing_event.v1"
accession: "0001665988-25-000032"
form_type: "8-K"
ticker: "BVS"
cik: "0001665988"
company_name: "Bioventus Inc."
filed_at: "2025-11-17T23:59:59+00:00"
generated_at: "2026-05-16T19:17:22.167128+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Bioventus appoints Ajay Dhankhar to board as Smith & Nephew designee

## Summary
- Appointment effective November 14, 2025; Dhankhar serves as Class II director until 2026 annual meeting.
- Dhankhar is Chief Corporate Development & Strategy Officer at Smith & Nephew (SNN) since June 2025.
- He is the second designee from S+N stockholders under the Stockholders Agreement.
- Dhankhar will not receive any compensation from Bioventus for board service.
- No family relationships or material interests in any transaction with the Company.

## SEC filing metadata
- accession: 0001665988-25-000032
- form_type: 8-K
- ticker: BVS
- cik: 0001665988
- company_name: Bioventus Inc.
- filed_at: 2025-11-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1665988/000166598825000032/0001665988-25-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1665988/000166598825000032/bvs-20251114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001665988-25-000032
- JSON: https://secwatch.observer/filing/0001665988-25-000032.json
- Plain text: https://secwatch.observer/filing/0001665988-25-000032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.